DoseMe Acquires Firstline to Create Integrated Clinical Decision Support Platform

November 3, 2025

DoseMe, a portfolio company of Fairlong Capital, has acquired Firstline, a Vancouver-based clinical decision support platform. The acquisition combines Firstline's infectious disease guidance and antimicrobial stewardship capabilities with DoseMe's model-informed precision dosing software to create an end-to-end clinical decision support solution for hospitals and health systems.

Buyers
DoseMe, Fairlong Capital
Targets
Firstline
Location
British Columbia, Canada
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.